The global health landscape is increasingly focusing on rare genetic disorders, with the Cat Eye Syndrome (CES) Market emerging as a specialized sector within medical diagnostics and multidisciplinary care. Valued at USD 2.59 billion in 2024, the market is on a steady growth path to reach USD 3.18 billion by 2032, expanding at a compound annual growth rate (CAGR) of 2.60%. https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/